Vieser Jaime 4

What Happened

Jaime Vieser, a director of Alaunos Therapeutics (TCRT), received an award of 6,515 shares of common stock on April 29, 2026. The shares were issued at an effective price of $2.59 per share, for a total value of approximately $16,874. This was an award issued in lieu of board fees (compensation), not an open-market purchase or sale.

Key Details

• Transaction date: April 29, 2026
• Transaction type/code: Award/Grant (A)
• Shares received: 6,515 at $2.59 per share — total value ≈ $16,874
• Shares held after transaction: Not reported in this Form 4 filing
• Footnote: Shares are directly held by Brushwood LLC; Mr. Vieser is the Manager of Brushwood LLC (F1).
• Filing: Form 4 filed May 1, 2026 (covers 4/29 transaction) — appears timely.

Context

These shares were issued as director compensation (in lieu of board fees), which is a routine corporate practice for paying non-employee board members. Awards like this are compensation-related and do not necessarily indicate the insider is buying or selling based on a view of the company’s near-term prospects.